A Nanoparticle-Based Combination Chemotherapy Delivery System for Enhanced Tumor Killing by Dynamic Rewiring of Signaling Pathways
Exposure to the EGFR (epidermal growth factor receptor) inhibitor erlotinib promotes the dynamic rewiring of apoptotic pathways, which sensitizes cells within a specific period to subsequent exposure to the DNA-damaging agent doxorubicin. A critical challenge for translating this therapeutic network...
Main Authors: | , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | en_US |
Published: |
American Association for the Advancement of Science (AAAS)
2014
|
Online Access: | http://hdl.handle.net/1721.1/91686 https://orcid.org/0000-0002-4954-8443 https://orcid.org/0000-0002-9547-3251 https://orcid.org/0000-0003-1727-5732 https://orcid.org/0000-0003-3988-0837 |